发明公开
EP2362727A1 METHODS FOR TREATING RESISTANT DISEASES USING TRIAZOLE CONTAINING MACROLIDES
有权
方法与TRAIZOLHALTIGEN大环内酯类耐药疾病治疗
- 专利标题: METHODS FOR TREATING RESISTANT DISEASES USING TRIAZOLE CONTAINING MACROLIDES
- 专利标题(中): 方法与TRAIZOLHALTIGEN大环内酯类耐药疾病治疗
-
申请号: EP09822827.3申请日: 2009-10-24
-
公开(公告)号: EP2362727A1公开(公告)日: 2011-09-07
- 发明人: PEREIRA, David, E. , FERNANDES, Prabhavathi, B.
- 申请人: Cempra Pharmaceuticals, Inc.
- 申请人地址: 6340 Quadrangle Drive, Suite 100 Chapel Hill, NC 27517 US
- 专利权人: Cempra Pharmaceuticals, Inc.
- 当前专利权人: Cempra Pharmaceuticals, Inc.
- 当前专利权人地址: 6340 Quadrangle Drive, Suite 100 Chapel Hill, NC 27517 US
- 代理机构: Elsy, David
- 优先权: US108110P 20081024; US108137P 20081024; US108112P 20081024; US108168P 20081024; US162109P 20090320; US108134P 20081024
- 国际公布: WO2010048600 20100429
- 主分类号: A01N43/04
- IPC分类号: A01N43/04
摘要:
Use of macrolide and ketolide antibiotics for the treatment of acute exposure and diseases caused by biodefence pathogens is described.
公开/授权文献
信息查询
IPC分类: